Hematuria differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 48: | Line 48: | ||
|- | |- | ||
| rowspan="45" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematuria | | rowspan="45" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematuria | ||
| rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |Glomerular | | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |IgA nephropathy (Berger nephropathy) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy (Berger nephropathy)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 71: | Line 71: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hereditary nephritis (Alport syndrome) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 93: | Line 93: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Poststreptococcal glomerulonephritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 115: | Line 115: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mesangioproliferative glomerulonephritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 137: | Line 137: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Focal segmental glomerular sclerosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 159: | Line 159: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 181: | Line 181: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Lupus nephritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 203: | Line 203: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Thin basement membrane disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thin basement membrane disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 225: | Line 225: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fabry disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fabry's disease|Fabry disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 247: | Line 247: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tubulointerstitial diseases | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tubulointerstitial diseases of the kidney|Tubulointerstitial diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal papillary necrosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 270: | Line 270: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acute interstitial nephritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial nephritis|Acute interstitial nephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 292: | Line 292: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Analgesic | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Analgesic]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 314: | Line 314: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Nephrolithiasis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrolithiasis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 336: | Line 336: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Reflux nephropathy (hydronephrosis) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Reflux nephropathy|Reflux nephropathy (hydronephrosis)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 358: | Line 358: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignancy | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignancy]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal cell carcinoma (RCC) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal cell carcinoma|Renal cell carcinoma (RCC)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 381: | Line 381: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Nephroblastoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephroblastoma]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 403: | Line 403: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Transitional cell carcinoma (TCC) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Transitional cell carcinoma|Transitional cell carcinoma (TCC)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 425: | Line 425: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prostate cancer | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostate cancer]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 447: | Line 447: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Familial diseases | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial|Familial diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Polycystic kidney disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polycystic kidney disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 470: | Line 470: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Medullary sponge kidney | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Medullary sponge kidney]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 492: | Line 492: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |Vascular | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Arteriovenous renal malformations | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation|Arteriovenous renal malformations]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 515: | Line 515: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal vein thrombosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 537: | Line 537: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignant hypertension | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignant hypertension]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 559: | Line 559: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Polyarteritis nodosa | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 581: | Line 581: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wegner's granulomatosis polyangiitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Granulomatosis with polyangiitis|Wegner's granulomatosis polyangiitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 603: | Line 603: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Henoch-Schönlein purpura | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 625: | Line 625: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Lower urinary tract diseases | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urinary system|Lower urinary tract diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign prostatic hyperplasia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign prostatic hyperplasia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 648: | Line 648: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Urolithiasis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urolithiasis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 670: | Line 670: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Interstitial cystitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 692: | Line 692: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Radiogenic cystitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 714: | Line 714: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Systemic diseases | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Coagulopathy (hemophilia) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 737: | Line 737: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sickle cell anemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 759: | Line 759: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Abdominal aortic aneurysm | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 781: | Line 781: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Lymphomas | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 803: | Line 803: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple myeloma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 825: | Line 825: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |Infectious diseases | | rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious disease|Infectious diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pyelonephritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyelonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 848: | Line 848: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cystitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 870: | Line 870: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prostatitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 892: | Line 892: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Urethritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 914: | Line 914: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epididymitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Epididymitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 936: | Line 936: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cytomegalovirus | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cytomegalovirus]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 958: | Line 958: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Infectious mononucleosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious mononucleosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 980: | Line 980: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Condylomata | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Condylomata acuminata]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,002: | Line 1,002: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Urogenital trauma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted bladder or ureteral catheters | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,025: | Line 1,025: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Drugs | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drugs]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Anticoagulants | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Anticoagulants]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,048: | Line 1,048: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: center;" |Dark urine | | rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dark urine]] | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" | | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemoglobinuria]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Autoimmune hemolytic anemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,072: | Line 1,072: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Microangiopathic hemolytic anemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Microangiopathic hemolytic anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,094: | Line 1,094: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Thrombotic | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thrombotic thrombocytopenic purpura]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,116: | Line 1,116: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Paroxysmal nocturnal hemoglobinuria | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Paroxysmal nocturnal hemoglobinuria]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,138: | Line 1,138: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Paroxysmal cold hemoglobinuria | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Paroxysmal cold hemoglobinuria]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,160: | Line 1,160: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Falciparum malaria | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malaria|Falciparum malaria]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,182: | Line 1,182: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prosthetic heart valve | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prosthetic heart valve]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,204: | Line 1,204: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" | | | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myoglobinuria]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crush injury | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,227: | Line 1,227: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vigorous muscle exercise | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Physical exercise|Vigorous muscle exercise]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,249: | Line 1,249: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hyperthermia (Heat stroke) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyperthermia|Hyperthermia (Heat stroke)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,271: | Line 1,271: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Electric shock | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electric shock]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,293: | Line 1,293: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prolonged seizure | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Prolonged [[seizure]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,315: | Line 1,315: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Polymyositis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polymyositis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,337: | Line 1,337: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Trichinosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Trichinosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,359: | Line 1,359: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Haff disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,381: | Line 1,381: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Animal venom bite | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bite injury|Animal venom bite]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,403: | Line 1,403: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Chemicals | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chemicals]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Phenazopyridine | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Phenazopyridine]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,426: | Line 1,426: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Beet (Beeturia) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Beeturia|Beet (Beeturia)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 19:32, 7 May 2018
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Gross hematuria | Causes of hematuria | Sub-entity | Causes and associations | History and Symtoms | Laboratory Findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
History | Shaking, chills and rigors | Fever | Nausea/vomiting | Dysuria | Frequency | Pitting edema | Hypertension | Hemoptysis | Oliguria | Peri-orbital edema (Facial puffiness) | Urinalysis | Cystoscopy | Hyperlipidemia and hypercholesterolemia | Nephrotic features | Nephritic features | ANCA | Anti-glomerular basement membrane antibody (Anti-GBM antibody) | Immune complex formation | Light microscope | Electron microscope | Immunoflourescence pattern | |||||
Urolithiasis (Renal stones)- may be microscopic |
|
|
|
+/- | +/- | + | + | - | - | - | - | + | - |
|
- | - | - | - | - | - | - | - | - | - | ||
Renal tumors- may be microscopic | ||||||||||||||||||||||||||
Renal cysts | ||||||||||||||||||||||||||
Prostatitis | ||||||||||||||||||||||||||
Benign prostatic hyperplasia (BPH)- may be micrscopic | ||||||||||||||||||||||||||
Anti-coagulant use- may be microscopic | Oral anticoagulant use | |||||||||||||||||||||||||
Heparin | ||||||||||||||||||||||||||
Aspirin | ||||||||||||||||||||||||||
Clopidogrel | ||||||||||||||||||||||||||
Ticlopidine | ||||||||||||||||||||||||||
Factor Xa inhibitors | ||||||||||||||||||||||||||
Bladder tumors- may be micrscopic | Transitional cell carcinoma |
|
|
- | - | +/- | +/- | - | - | - | - | - | ||||||||||||||
Urinary tract infection- may be microscopic | ||||||||||||||||||||||||||
Tuberculosis | ||||||||||||||||||||||||||
Schistomsomiasis | ||||||||||||||||||||||||||
Hemorrhagic cystitis | ||||||||||||||||||||||||||
Renal infarction | ||||||||||||||||||||||||||
Recent urologic procedure | ||||||||||||||||||||||||||
Microscopic hematuria | Glomerulonephritides | Non-proliferative | Minimal change disease |
|
|
+ | - | - | +/- | - | + | + | - | - | - | - |
|
|
- | |||||||
Focal segmental glomerulosclerosis |
|
|
+ | - | - | +/- | - | + | + | - | - | - | - |
|
|
- | ||||||||||
Membranous glomerulonephritis |
|
+ | - | - | +/- | - | + | + | - | - | - | + |
|
|
- | |||||||||||
Proliferative | IgA nephropathy |
|
|
+/- | + | - | + | +/- | - | - | + | - | - | + |
|
|
- | |||||||||
Rapidly progressive glomerulonephritis |
|
|
+/- | + | + | + | + | - | - | + | - | + | + |
|
|
+ (Linear) | ||||||||||
|
|
+/- | + | + | + | + | - | - | + | - | - | + |
|
|
+ (Granular) | |||||||||||
|
|
+/- | + | + | + | + | - | - | + | + (C-ANCA) | - | - |
|
- (pauci-immune) | +/- | |||||||||||
|
|
+/- | + | + | + | + | - | - | + |
+ (C-ANCA) |
- | - |
|
- (pauci-immune) | - | |||||||||||
|
|
+/- | + | + | + | + | - | - | + |
+ (P-ANCA) |
- | - |
|
- (pauci-immune) | - | |||||||||||
Membranoproliferative glomerulonephritis |
|
|
+/- | + | + | + | + | - | + | - | - | - | + |
|
|
+ (Granular) | ||||||||||
Henoch-Schonlein purpura | ||||||||||||||||||||||||||
Alport's syndrome | ||||||||||||||||||||||||||
Diabetic glomerulosclerosis | ||||||||||||||||||||||||||
Interestitial nephritis | ||||||||||||||||||||||||||
Renal papillary necrosis | ||||||||||||||||||||||||||
Renal artery stenosis |